Competition

Competition — Partners Group Holding AG

Competitive Bottom Line

Partners Group's moat is real but narrow, and concentrated in one product line: the bespoke multi-asset mandate. With 67% of AuM in mandates plus evergreens — by far the highest in the listed-alts cohort — PGHN earns a 60.1% EBIT margin and a 55% ROE on a fee-only, asset-light book that no large peer can match without first stripping out an insurance balance sheet. That edge is genuine but it does not protect the firm on every front. The single competitor that matters most is Blackstone: BX has a five-to-eight-year head start in the wealth channel (BREIT, BCRED, BXPE alone hold more retail evergreen capital than PGHN's entire evergreen book) and is moving fastest where PGHN must grow. EQT and Hamilton Lane are the closer pure-play comparables on economics, but neither sets the strategic tempo for the industry the way Blackstone does.

The Right Peer Set

Five listed peers cover PGHN's competitive surface. EQT and Bridgepoint are the European-listed private-markets pure-plays — the same business model, same fee structure, same LP base. Hamilton Lane is the closest economic match for the 70% of PGHN's AuM that is bespoke solutions (customised portfolios, secondaries, co-investments). Blackstone and KKR are not direct peers on customisation but they set the scale benchmark, the wealth-channel pace, and the M&A premium that the equity market pays for an alternative-asset franchise. The four US giants kept as "supplementary" (APO, ARES, BAM, CG) overlap PGHN on individual asset classes but each has a defining business that PGHN does not: credit/insurance (APO/ARES), real-assets (BAM), or legacy PE-only (CG).

The pure-play European pair (EQT, BPT) and the solutions specialist (HLNE) explain how PGHN's economics compare in a like-for-like cohort. The US scale players explain what PGHN must defend against in the next leg of the industry's evolution.

Market caps as of May 2026 (Yahoo Finance); AuM from latest FY2025 disclosures. Enterprise value shown N/A for BX, KKR, APO, CG — Yahoo's summary EV for these names was missing or inconsistent at the run date (APO's reported EV scraped as negative; CG and BX were blank); debt/cash were not retrieved in this run to compute the figure cleanly, so the EV column is left empty rather than guessed. KKR EBIT margin marked null because consolidated revenue includes Global Atlantic insurance net premiums that distort the gross-margin line (operating margin reads 3.8% on $19.5bn revenue but is not comparable to a pure GP).

PGHN sits in the lower-right quadrant the market typically rewards: highest EBIT margin of any peer, lowest P/E of the group except for Hamilton Lane. EQT trades at 2.7x PGHN's multiple on a margin 24 percentage points lower. The gap to Hamilton Lane is the most telling — both are high-margin asset-light specialists trading at near-identical multiples, and both carry a wealth-channel growth story the market has not paid for yet.

Where The Company Wins

1. Bespoke share — the structural moat

The single most informative competitive number is the share of AuM that sits in tailored mandates and evergreen vehicles rather than traditional closed-end commingled funds. Mandates are individually negotiated contracts (often perpetual, no defined termination); evergreens are open-ended funds where investors can be added continuously. Both are far stickier than closed-end LP funds, where the manager has to re-raise every 4-6 years.

PGHN's 67% bespoke share is matched only by Hamilton Lane (which built its entire business model around it). Among the scale alts, only Blackstone is moving aggressively to close the gap — its retail-channel evergreens (BREIT, BCRED, BXPE) are well-disclosed and growing, but they are still a smaller share of BX's $1.24tn AuM than mandates+evergreens are of PGHN's $185bn. Source: PGHN AR2025 client section and CMD 2026; peer figures triangulated from FY2025 10-K/annual report business descriptions in data/competitors/*/annual_report/.

2. Asset-light economics — no balance-sheet distortion

PGHN's 60.1% EBIT margin and 55% return on equity are the cleanest in the cohort because there is no insurance subsidiary or large balance-sheet investment book to flatter the numbers. The contrast with KKR is the most extreme: KKR's consolidated revenue includes Global Atlantic insurance premiums, which drag reported operating margin to 3.8% even though the GP business is very profitable. Apollo runs the same insurance-funded model via Athene. PGHN's margin is the underlying GP margin; theirs is a blended number that requires segment adjustments to interpret.

PGHN ROE of 55% with no insurance subsidy is genuinely top-of-class. The next-cleanest comps — Hamilton Lane (39%) and BAM (23%) — both run materially lower returns because their fee mixes are weighted toward lower-take-rate products (advisory at HLNE, real-assets at BAM).

3. Realisation execution — share gain in the 2025 reopening

PGHN realised USD 26bn of investments in 2025 (+47% YoY) while the broader industry realisations grew approximately 5% per Preqin (industry data cited in PGHN AR2025). Fundraising followed: PGHN raised USD 26bn in 2025 (+22% YoY) vs industry fundraising down 4% over the same period. Two consecutive years of share-gain in a slow market is the strongest evidence that the bespoke moat translates into commercial outcomes when the cycle turns.

Compare what peers showed in 2025 reported revenue:

PGHN's 20% reported revenue growth (24% constant-currency) puts it in the top half of the cohort, materially ahead of EQT (-1%) and the consolidated US giants distorted by insurance revenue (KKR -11%, APO -1%). Bridgepoint's 47% top-line was off a much smaller base and on a deteriorating margin (net margin fell from 16% to 9%); PGHN held a 49% net margin alongside the growth.

4. Fee-margin stability — the pricing-discipline proof

Across FY2015–FY2025 the PGHN management-fee margin held in a 1.18–1.33% band — through COVID, the 2021 mega-cycle, the 2022–24 drought, and the 2025 reopening. No listed peer can show this stability for a comparable horizon because almost all of them changed business mix materially over the decade (BX added insurance via partnerships, KKR closed Global Atlantic, APO closed Athene, BAM spun out the asset-light entity). Hamilton Lane is the only peer with a comparable pricing-discipline record, and it comes from running a solutions-only book.

The implication is that PGHN's clients pay for the portfolio-construction service, not for individual fund access. That price point is what wealth platforms cannot easily replicate by white-labelling someone else's fund. It is also what is most at risk if the wealth channel eventually demands fee concessions in exchange for distribution.

Where Competitors Are Better

1. Blackstone — wealth-channel scale and infrastructure

Blackstone's retail-aimed evergreen book (BREIT real-estate income trust, BCRED private credit, BXPE private equity) has been built since 2017 and now sits at a scale that PGHN's evergreen platform cannot match in absolute terms. BREIT alone was reported at well over $60bn NAV in BX's FY2025 10-K; BCRED has been the fastest-growing private-credit BDC; BXPE was launched in 2023 as the retail private-equity vehicle. PGHN is launching its own equivalents (PG ENG private equity evergreen, mature credit evergreens), but the comparison is years vs months of distribution build, and dozens vs handfuls of wirehouse selling agreements.

Source: BX FY2025 10-K business description (data/competitors/BX/annual_report/FY2025/business.txt). The reader should treat BX's wealth platform as a structural advantage that money cannot quickly close.

2. Apollo / KKR — insurance permanent capital

Apollo's merger with Athene and KKR's acquisition of Global Atlantic gave both firms hundreds of billions of dollars of permanent fee-paying capital that doesn't have to be re-raised. The capital comes from insurance liabilities that the firms manage at private-market spreads — a structurally cheaper distribution channel than fundraising. PGHN's asset-light pure-GP model is, by design, the opposite — every dollar of AuM is client commitment that has to be won and re-won. In a slow institutional vintage, insurance balance sheets keep growing while LP fundraising falls.

Source: APO FY2025 10-K (data/competitors/APO/annual_report/FY2025/business.txt) and KKR FY2025 10-K (data/competitors/KKR/annual_report/FY2025/business.txt). The cost: BX and KKR's reported operating margins are unrepresentative because of insurance accounting, but the AuM compounds without traditional fundraising friction.

3. Pure scale — BX, KKR, BAM on "core platform" RFPs

A pension or sovereign wealth fund reviewing its private-markets allocation for the next five years will typically run a "core platform" RFP — a multi-billion-dollar commitment over multiple strategies to a single GP. The list of GPs invited to that RFP is short and dominated by the firms with $500bn+ in AuM and a complete product shelf. PGHN at $185bn AuM makes that list often (the firm has called out share-gain to "concentrating LP commitments"), but the firms on the list every time are BX, KKR, BAM and the big private GPs (Bain, CVC, Permira). At 6-8x smaller by AuM than the largest scale players, PGHN trades off "always invited" for "differentiated when invited."

4. EQT — pricing power on European mid-market PE

EQT raised the EQT X flagship buyout fund at €22bn in 2023 and the EQT XI is expected to scale further. In the European mid-market PE pool where PGHN deploys roughly a quarter of its PE AuM, EQT is the share leader by deal volume and by LP wallet, and competes on most of the same deals. EQT's brand in the German/Nordic LP universe is the strongest, and recent EQT vintages have published strong realised IRRs (the FY2024 +29% net income jump and FY2025 36% EBIT margin came from accelerated PE realisations).

The implication for PGHN: in the highest-overlap product area, the head-to-head share competition is roughly even, and PGHN does not have meaningful pricing power vs EQT on closed-end PE funds. The pricing power lives in mandate/evergreen architecture, not in fund-level fees.

Threat Map

Moat Watchpoints

The five signals below are the measurable evidence an investor should track every six months. Each is observable in PGHN's interim/annual reporting or in peer disclosure, and each has a clear direction that signals moat improvement or moat erosion.

The hierarchy among these five: #1 (bespoke share) and #2 (fee margin) are the dominant moat-integrity signals — both move slowly but a sustained move in either direction would re-rate the equity. #3 (wealth-channel disclosure) is the most under-priced near-term catalyst — PGHN currently bundles the wealth narrative qualitatively, and any move to disclose a discrete wealth-channel AuM line item with growth would clarify the bull case. #4 (realisations) and #5 (NAM share) are cycle and execution markers — useful for confirming the trajectory, but they do not in themselves prove the moat.